HDSA RESEARCH WEBINAR: Update from PTC Therapeutics on the PIVOT-HD Trial

(39:50)

Phase II PIOVT-HD trial of PTC518 in early Huntington's disease

(3:35)

HDSA RESEARCH WEBINAR: HD Clinical Trial Update

(1:40)

HDSA RESEARCH WEBINAR: Novartis Discusses the VIBRANT-HD Trial

(56:56)

What Clinical Trials Taught Us and How HD Therapeutic Development is Accelerating in 2022

(48:25)

An Update on HD Clinical Trials in Canada

(58:15)

The Trial

(5:19)

HD TRIALS – WHAT HAPPENED AND WHAT’S NEXT

(27:43)

GMMG-HD7 Clinical Trial for Patients With Multiple Myeloma

(5:32)

PROOF-HD: Phase III trial of oral S1R agonist pridopidine for the treatment of Huntington’s disease

(5:38)

WEBINAR: Updates on the Select HD clinical trial on Huntington's Disease

(51:15)

Clinical Trial Showcase

(18:34)

CLINICAL TRIAL SHOWCASE | 37th Annual #HDSAConvention

(1:16:30)

First-HD overview - A Huntington Disease Clinical Trial

(5:51)

PROOF-HD: Pivotal Huntington Disease Trial Underway

(6:29)

Vibrant HD - Novartis clinical trial for Huntington's Disease

(9:1econd)

38th Annual HDSA Convention Clinical Trials Showcase

(1:4:45)

QUICK QUESTION: What is HDSA's HD Trialfinder?

(1:11)

HD Trial Finder - The European webpage where all ongoing trials are presented in plain language

(1:25)

HSC x HDSA Research Webinar: Data from the Phase 3 PROOF HD Trial of Pridopidine

(1:5:12)